Overview

Perioperative Treatment With TAS-102 in Combination With Oxaliplatin for Locally Advanced Rectal Cancer

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2028-05-01

Target enrollment:

Participant gender:

Summary

5-Fluorouracil (5-FU) based chemoradiotherapy is regarded a standard perioperative treatment in locally advanced rectal cancer, but the effective rate still low. We investigate oral TAS-102 plus oxaliplatin concurrent radiotherapy for stage II or III local advanced rectal cancer.

Phase:

PHASE2

Details

Lead Sponsor:

Qingdao Central Hospital

Treatments:

Oxaliplatin
trifluridine tipiracil drug combination